$766 Million is the total value of Foyston, Gordon, & Payne Inc's 85 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BRKA | Berkshire Hathaway Inc.-CL A | $7,328,000 | +1.1% | 43 | 0.0% | 0.96% | -11.4% | |
KO | Coca Cola Co. | $3,550,000 | -5.6% | 93,720 | 0.0% | 0.46% | -17.3% | |
RFP | Resolute Forest Products | $3,446,000 | +4.1% | 251,344 | 0.0% | 0.45% | -8.7% | |
BRKB | Berkshire Hathaway Inc. CL B | $1,853,000 | +1.4% | 16,323 | 0.0% | 0.24% | -11.0% | |
MDLZ | Mondelez International Inc. | $1,736,000 | +10.2% | 55,256 | 0.0% | 0.23% | -3.4% | |
WMT | Wal-Mart Stores Inc. | $1,476,000 | -0.7% | 19,950 | 0.0% | 0.19% | -12.7% | |
KRFT | Kraft Foods Group Inc. | $966,000 | -6.1% | 18,418 | 0.0% | 0.13% | -17.6% | |
PG | Procter & Gamble Co. | $798,000 | -1.8% | 10,563 | 0.0% | 0.10% | -14.0% | |
MMM | 3M Co. | $767,000 | +9.3% | 6,424 | 0.0% | 0.10% | -3.8% | |
BDX | Becton Dickinson & Co. | $630,000 | +1.1% | 6,300 | 0.0% | 0.08% | -11.8% | |
IBM | IBM | $579,000 | -3.0% | 3,126 | 0.0% | 0.08% | -14.6% | |
ABBV | AbbVie Inc. | $562,000 | +8.1% | 12,570 | 0.0% | 0.07% | -5.2% | |
UTX | United Technologies Corp. | $559,000 | +16.0% | 5,185 | 0.0% | 0.07% | +1.4% | |
IVV | IShares S&P 500 Index Fund | $524,000 | +5.0% | 3,100 | 0.0% | 0.07% | -8.1% | |
ABT | Abbott Laboratories | $417,000 | -4.8% | 12,570 | 0.0% | 0.05% | -16.9% | |
USB | U.S. Bancorp. | $349,000 | +1.2% | 9,553 | 0.0% | 0.05% | -9.8% | |
WFC | Wells Fargo Co. | $307,000 | +0.3% | 7,421 | 0.0% | 0.04% | -13.0% | |
JPM | JPMorgan Chase & Co. | $231,000 | -2.1% | 4,471 | 0.0% | 0.03% | -14.3% | |
ACETQ | Aceto Corp. | $185,000 | +12.1% | 11,851 | 0.0% | 0.02% | -4.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Frank Russell Company #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2013-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Microsoft Corp. | 42 | Q3 2023 | 10.2% |
Johnson & Johnson | 42 | Q3 2023 | 9.3% |
Mondelez International Inc. | 42 | Q3 2023 | 4.0% |
Coca Cola Co. | 42 | Q3 2023 | 1.7% |
Berkshire Hathaway Inc. CL B | 42 | Q3 2023 | 1.6% |
Becton Dickinson & Co. | 42 | Q3 2023 | 2.7% |
Wal-Mart Stores Inc. | 42 | Q3 2023 | 0.9% |
AbbVie Inc. | 42 | Q3 2023 | 0.5% |
Abbott Laboratories | 42 | Q3 2023 | 0.4% |
Procter & Gamble Co. | 42 | Q3 2023 | 0.2% |
View Foyston, Gordon, & Payne Inc's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Foyston, Gordon, & Payne Inc | September 20, 2012 | 4,798,387 | 4.8% |
Foyston, Gordon, & Payne Inc | April 25, 2012 | 8,966,382 | 9.2% |
TECUMSEH PRODUCTS CO | July 17, 2006 | 553,579 | 4.1% |
CPI CORPSold out | April 27, 2006 | 0 | 0.0% |
View Foyston, Gordon, & Payne Inc's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-07 |
13F-HR | 2024-02-07 |
13F-HR | 2023-10-26 |
13F-HR | 2023-08-01 |
13F-HR | 2023-05-03 |
13F-HR | 2023-02-09 |
13F-HR | 2022-11-04 |
13F-HR | 2022-08-11 |
13F-HR | 2022-04-27 |
13F-HR | 2022-02-11 |
View Foyston, Gordon, & Payne Inc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.